• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose.

作者信息

Mahapatra Manoranjan, Mishra Pravas, Kumar Rajat

出版信息

Ann Hematol. 2007 Jul;86(7):537-8. doi: 10.1007/s00277-007-0265-y. Epub 2007 Feb 8.

DOI:10.1007/s00277-007-0265-y
PMID:17287945
Abstract
摘要

相似文献

1
Imatinib-induced Stevens-Johnson syndrome: recurrence after re-challenge with a lower dose.伊马替尼诱导的史蒂文斯-约翰逊综合征：低剂量再次激发后复发
Ann Hematol. 2007 Jul;86(7):537-8. doi: 10.1007/s00277-007-0265-y. Epub 2007 Feb 8.
2
[Glivec induced autoimmune hepatitis].
Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):982-4. doi: 10.1016/j.gcb.2009.07.034. Epub 2009 Sep 17.
3
Partial fanconi syndrome induced by imatinib therapy: a novel cause of urinary phosphate loss.伊马替尼治疗引起的部分范科尼综合征：尿磷丢失的新原因。
Am J Kidney Dis. 2008 Feb;51(2):298-301. doi: 10.1053/j.ajkd.2007.10.039.
4
Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):288-9. doi: 10.4103/0378-6323.16628.
5
Imatinib-lnduced agranulocytosis in a patient with chronic myelogenous leukemia in remission.伊马替尼诱导一名处于缓解期的慢性粒细胞白血病患者发生粒细胞缺乏症。
Isr Med Assoc J. 2008 Apr;10(4):320-1.
6
Multicenter prospective trial evaluating the tolerability of imatinib for Japanese patients with chronic myelogenous leukemia in the chronic phase: does body weight matter?评估伊马替尼对日本慢性期慢性粒细胞白血病患者耐受性的多中心前瞻性试验：体重有影响吗？
Am J Hematol. 2008 Nov;83(11):835-9. doi: 10.1002/ajh.21274.
7
Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.慢性髓性白血病完全细胞遗传学缓解后与伊马替尼相关的骨髓再生障碍
J Coll Physicians Surg Pak. 2008 Mar;18(3):176-8.
8
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib.伊马替尼血液学或细胞遗传学耐药之前BCR-ABL突变克隆的动态变化。
Haematologica. 2008 Feb;93(2):186-92. doi: 10.3324/haematol.11993. Epub 2008 Jan 26.
9
Development of c-Kit-expressing small-cell lung cancer in a chronic myeloid leukemia patient during imatinib treatment.
J Natl Cancer Inst. 2004 Nov 17;96(22):1723-4. doi: 10.1093/jnci/djh330.
10
Stevens-Johnson syndrome induced by combination of imatinib and allopurinol.伊马替尼与别嘌醇联用诱发的史蒂文斯-约翰逊综合征。
Chemotherapy. 2009;55(4):197-9. doi: 10.1159/000218097. Epub 2009 May 11.

引用本文的文献

1
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.免疫检查点抑制剂和肿瘤靶向治疗诱导的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的新见解
J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.
2
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review).与酪氨酸激酶抑制剂相关的潜在危及生命的严重皮肤不良反应（综述）。
Oncol Rep. 2021 Mar;45(3):891-898. doi: 10.3892/or.2020.7911. Epub 2020 Dec 24.
3
Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.
靶向抗癌疗法和免疫疗法引起的严重皮肤不良反应。
Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018.
4
Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.抗癌药物引起的严重皮肤不良反应：抗癌靶向治疗或免疫治疗相关风险的最新综述。
J Immunol Res. 2018 Jan 17;2018:5376476. doi: 10.1155/2018/5376476. eCollection 2018.
5
Serious skin reaction associated with imatinib in a patient with chronic myeloid leukemia.一名慢性髓性白血病患者中与伊马替尼相关的严重皮肤反应。
Eurasian J Med. 2011 Dec;43(3):192-5. doi: 10.5152/eajm.2011.42.
6
Life-threatening dermatologic adverse events in oncology.肿瘤学中危及生命的皮肤不良反应。
Anticancer Drugs. 2014 Feb;25(2):225-34. doi: 10.1097/CAD.0000000000000032.
7
Skin and oral lesions associated to imatinib mesylate therapy.
Support Care Cancer. 2009 Apr;17(4):465-8. doi: 10.1007/s00520-008-0536-8. Epub 2008 Nov 27.